Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II
Clinical trial NCT05385250 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05385250
- Sponsor
- Karen-Lise Garm Spindler
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-23
- Primary completion
- 2025-01-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.